JPMorgan lowered the firm’s price target on Illumina (ILMN) to $85 from $120 and keeps a Neutral rating on the shares. The firm says that despite the solid Q1 results, the dynamic tariff environment, uncertainty on U.S. academic funding, export restrictions into China as well as evolving competitive dynamics limit the company’s near-term visibility.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ILMN:
- Illumina’s Financial Outlook: Hold Rating Amidst Export Bans and Tariff Challenges
- Illumina Reports Q1 2025 Financial Results Amid Challenges
- Closing Bell Movers: Pinterest jumps 15%, Toast up 7% after earnings
- Illumina reports Q1 adjusted EPS 97c, consensus 94c
- Illumina cuts FY25 adjusted EPS view to $4.20-$4.30 from $4.50, consensus $4.46